Our previous studies have demonstrated that the level of plasma Hsp90α is positively correlated with the tumor malignancy in clinical cancer patients and the secreted Hsp90α stabilizes MMP-2 to facilitate tumor invasion [24, 25]. The gene discussed is HSP90AA1; the disease is cancer.